Literature DB >> 25155765

Association between the ABO blood group and risk of common cancers.

Bei Li1, Bin Tan, Chunxia Chen, Li Zhao, Li Qin.   

Abstract

OBJECTIVE: To investigate the association between five common cancers in western China population and ABO blood group.
METHODS: Using the data from West China Hospital, we retrospectively reviewed 5012 patients with five common cancers. Blood groups were obtained from medical records. The control group was represented by 1979 health check-up examinees. The distributions of ABO blood types of certain cancer patients were investigated to assess the possible correlation between certain cancers and the ABO blood groups. A further meta-analysis was performed based on the studied results to find potential correlation between the ABO blood types and the risk of diseases.
RESULTS: A 24.5% increased risk was found in gastric cancer cases with blood type A when compared with those with blood type O (OR = 1.245, 95% CI 1.014 to 1.529, P = 0.036) from our data analysis. This association was further confirmed by the meta-analysis of nine studies (OR = 1.25, 95% CI = 1.12 to 1.39).
CONCLUSIONS: Our data suggested that blood type A was associated with gastric cancer.
© 2014 Chinese Cochrane Center, West China Hospital of Sichuan University and Wiley Publishing Asia Pty Ltd.

Entities:  

Keywords:  ABO blood group; H. pylori infection; gastric cancer; peptic ulcer

Mesh:

Substances:

Year:  2014        PMID: 25155765     DOI: 10.1111/jebm.12098

Source DB:  PubMed          Journal:  J Evid Based Med        ISSN: 1756-5391


  9 in total

1.  Thyroid volume and its relation to anthropometric measures in a healthy cuban population.

Authors:  Silvia Turcios; Juan J Lence-Anta; Jose-Luis Santana; Celia M Pereda; Milagros Velasco; Mae Chappe; Idalmis Infante; Marlene Bustillo; Anabel García; Enora Clero; Stephane Maillard; Regla Rodriguez; Constance Xhaard; Yan Ren; Carole Rubino; Rosa M Ortiz; Florent de Vathaire
Journal:  Eur Thyroid J       Date:  2015-02-26

2.  ABO Blood Group Differentials on Survival in Hepatocellular Carcinoma Patients Treated with Chemoembolization.

Authors:  Kittipitch Bannangkoon; Keerati Hongsakul; Pimsiri Sripongpun; Apichat Kaewdech; Naichaya Chamroonkul; Teeravut Tubtawee; Teerha Piratvisuth
Journal:  Asian Pac J Cancer Prev       Date:  2021-11-01

3.  ABO blood type correlates with survival in hepatocellular carcinoma following hepatectomy.

Authors:  Tao Wu; Xiao-An Ma; Guo-Qing Wang; Qing Li; Miao-Jing Li; Jin-Yue Guo; Xuan Liang; Zhi-Ping Ruan; Tao Tian; Ke-Jun Nan; Li-Na Liu; Hui Guo
Journal:  Sci Rep       Date:  2017-06-30       Impact factor: 4.379

4.  Novel characteristics of alpha-fetoprotein (AFP)-producing gastric cancer.

Authors:  Wenhui Sun; Baoqing Liu; Juntao Chen; Ping Gong; Xiaoying Wu; Chen Liu; Bo Hong; Weihua Gong
Journal:  Oncotarget       Date:  2017-10-30

5.  Different Risk Profiles for the Postsurgical Prognosis of Gastric Cancer Patients with Different Blood Types: The FIESTA Study.

Authors:  Guohui Fan; Dan Hu; Feng Peng; Guodong Xu; Xiandong Lin; Binying Liang; Hejun Zhang; Yan Xia; Jinxiu Lin; Xiongwei Zheng; Wenquan Niu
Journal:  J Cancer       Date:  2018-07-30       Impact factor: 4.207

6.  Impact of blood group on survival following critical illness: a single-centre retrospective observational study.

Authors:  Robert Slade; Raza Alikhan; Matt P Wise; Lam Germain; Simon Stanworth; Matt Morgan
Journal:  BMJ Open Respir Res       Date:  2019-06-29

7.  Association between Blood Group and Nonmelanoma Skin Cancers (Basal Cell Carcinoma and Squamous Cell Carcinoma).

Authors:  Dijana Celić; Jasna Lipozenčić; Branko Kolarić; Goran Ferenčak; Jolanda Kanižaj Rajković; Tajana Borlinić
Journal:  Int J Environ Res Public Health       Date:  2019-06-27       Impact factor: 3.390

8.  ABO blood groups and hepatitis B virus infection: a systematic review and meta-analysis.

Authors:  Wenzhan Jing; Siyu Zhao; Jue Liu; Min Liu
Journal:  BMJ Open       Date:  2020-02-02       Impact factor: 2.692

9.  ABO blood classification and the risk of lung cancer: A meta-analysis and trial sequential analysis.

Authors:  Haotian Yang; Ziqi Tan; Yizhen Zhang; Jiaqi Sun; Peng Huang
Journal:  Oncol Lett       Date:  2022-08-12       Impact factor: 3.111

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.